Last, the in vivo silencing efficacy of SAMiRNAs was evaluated by targeting amphiregulin and connective tissue growth factor in bleomycin or TGF-&#946; transgenic animal models of pulmonary fibrosis.
C0034069
Pulmonary Fibrosis